ARCHIVES

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Niederhuber Leads AACI

November 2, 2001

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

Overdiagnosis Since Advent Of Prostate Cancer Screening

September 25, 2009